COVID-19 and Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers - What Is the Evidence?

This viewpoint reviews speculation that these medicines might worsen clinical outcomes for patients with COVID-19; and summarises guidance from specialty societies to continue these drugs in patients who need them pending more definitive evidence of harm.


Journal of the American Medical Association